Wikipedia -WSS

Wikipedia

author：focus 2025-09-27 12:36:35 - browse：578

Who polices algorithms? How would you name the first approved CRISPR medicine? And what pairs well with a biotech downturn?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Casey Ross joins us to tell the bombshell story of how the nation’s largest health insurer used a computer algorithm to deny patient care and boost its profitability. Then, biotech veteran Michael Gilman calls in to offer a behind-the-scenes peek at what it’s like to be a startup CEO in this economic downturn — and which cocktail recipes help make it bearable. We also discuss a pioneering approval for a genome-editing medicine.

For more on what we cover, here’s the UnitedHealth story; here’s more on the CRISPR approval; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Medicare details structure of new drug price negotiation program
Next article： How to make AI work for medicine

hotspot

WSS

FDA's Pazdur wants cancer trials to range beyond China alone

Radiation, mainstay of cancer treatment, begins a fade

How Long Island became the ‘eugenics capital of the world’

Departing Stanford president retracts two papers

The Pandemic Treaty must support building strong health systems

What AAP's gender

hotspot

Wikipedia

Wikipedia

Apple is now the first public company to be valued at $3 trillion

NIH documents show early flaws of $1.6 billion long Covid program

Moonlake's readout produced a cash windfall. Risks remain

Innovation in antibiotics is ailing. 'Brain drain' may kill it

In Memoriam: Notable people who died in 2023

BMI, flaws aside, is found to be useful estimate of body fat in youth

BioMarin wins approval for gene therapy to treat hemophilia A

Drug firms test therapies to halt Alzheimer’s before symptoms arise

Medicare proposal to cover medical devices draws a mixed reaction

Drug firms test therapies to halt Alzheimer’s before symptoms arise

knowledge

Apellis safety probe of eye disease drug centers on injection needle

Medicare explains how it will choose drugs for negotiation

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

With trial win, GSK could get blood cancer drug back on market

How a symptom of dementia informs our understanding of creativity

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

focus

explore

hotspot

focus